Personalized in vitro Extracellular Matrix Models of Collagen VI-Related Muscular Dystrophies

Author:

Almici Enrico,Chiappini Vanessa,López-Márquez Arístides,Badosa Carmen,Blázquez Blanca,Caballero David,Montero Joan,Natera-de Benito Daniel,Nascimento Andrés,Roldán Mònica,Lagunas Anna,Jiménez-Mallebrera Cecilia,Samitier Josep

Abstract

Collagen VI-related dystrophies (COL6-RDs) are a group of rare congenital neuromuscular dystrophies that represent a continuum of overlapping clinical phenotypes that go from the milder Bethlem myopathy (BM) to the severe Ullrich congenital muscular dystrophy, for which there is no effective treatment. Mutations in one of the three Collagen VI genes alter the incorporation of this protein into the extracellular matrix (ECM), affecting the assembly and the structural integrity of the whole fibrillar network. Clinical hallmarks of COL6-RDs are secondary to the ECM disruption and include muscle weakness, proximal joint contractures, and distal hyperlaxity. Although some traits have been identified in patients’ ECMs, a correlation between the ECM features and the clinical phenotype has not been established, mainly due to the lack of predictive and reliable models of the pathology. Herein, we engineered a new personalized pre-clinical model of COL6-RDs using cell-derived matrices (CDMs) technology to better recapitulate the complexity of the native scenario. We found that CDMs from COL6-RD patients presented alterations in ECM structure and composition, showing a significantly decreased Collagen VI secretion, especially in the more severe phenotypes, and a decrease in Fibrillin-1 inclusion. Next, we examined the Collagen VI-mediated deposition of Fibronectin in the ECM, finding a higher alignment, length, width, and straightness than in patients with COL6-RDs. Overall, these results indicate that CDMs models are promising tools to explore the alterations that arise in the composition and fibrillar architecture due to mutations in Collagen VI genes, especially in early stages of matrix organization. Ultimately, CDMs derived from COL6-RD patients may become relevant pre-clinical models, which may help identifying novel biomarkers to be employed in the clinics and to investigate novel therapeutic targets and treatments.

Funder

Ministerio de Economía, Industria y Competitividad, Gobierno de España

Instituto de Salud Carlos III

“la Caixa” Foundation

H2020 Marie Skłodowska-Curie Actions

Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina

Ministerio de Ciencia, Innovación y Universidades

FP7 People: Marie-Curie Actions

Generalitat de Catalunya

Publisher

Frontiers Media SA

Subject

Biomedical Engineering,Histology,Bioengineering,Biotechnology

Reference66 articles.

1. ColVI Myopathies: Where Do We Stand, where Do We Go?;Allamand;Skelet. Muscle,2011

2. Engineering Cell-Derived Matrices with Controlled 3D Architectures for Pathophysiological Studies;Almici,2020

3. Tendon Extracellular Matrix Remodeling and Defective Cell Polarization in the Presence of Collagen VI Mutations;Antoniel;Cells,2020

4. Cell-Derived Extracellular Matrix for Tissue Engineering and Regenerative Medicine;Assunção;Front. Bioeng. Biotechnol.,2020

5. Tissue-Engineered Disease Models;Autonomous;Nat. Biomed. Eng.,2018

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3